Anyone else on Daraxonrasib (RMC-6236)?

A drug nearing regulatory approval, daraxonrasib, is the first to substantially extend the lives of patients with pancreatic cancer. It works by targeting a cellular protein that fuels not just nearly all pancreatic tumors, but also many lung and colon cancers. Those three are the leading causes of cancer deaths.
Marylyn new article

Is this drug specific to the KRAS mutation? Is it being also tested on non-KRAS patients?

@owlladycpl Did Duke say they can give you the pill? It is not available without trial qualification and approval from Rev Med drug company.

Please know that while the skin issues are annoying, the company has found several different topical creams and prescription antibiotics that can head the worst of this off. Ask for these upfront. Also. This drug is not FDA approved so they have to supply it directly. They are not a large scale manufacturer so this may take a little time to disperse.
I know many people that have been in the trial for the drugs over 2 years! They have found ways to deal with the skin so don’t let that create too much anxiety !

@owlladycpl
after her doc fills out the application it has to be approved by the manufacturer. We are waiting too!

My daughter has pancreatic cancer and has had the #2 chemo but it didn't help. Now they are waiting for the Daraxonrasib pill. Why the wait? It seems Duke would be able to get the pill when needed. Anyone have anything to say as why the wait?